Three key elements to improve physician outreach
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
The COVID-19 pandemic illustrated how vital government communications can be for effective public...
As real-world data (RWD) continues to be increasingly utilized by the pharmaceutical industry and...
Medicaid provides much-needed healthcare coverage to over 70 million people, almost half of whom...
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent...
While the CDC is considered the nation’s leading authority on infectious diseases, it is also...
Our series on how Privacy Preserving Record Linkage (PPRL) technology can help government agencies...
In our ongoing series on how Privacy-Preserving Record Linkage (PPRL) technology can help...
Healthcare brand marketing is at a crossroads. With patients taking a more active role in their...
In our series on how Privacy-Preserving Record Linkage (PPRL) technology can help government...
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought together leaders from biopharma, government, and data science to explore how real-world data is transforming evidence generation across the drug devel...